Clinical characteristics and follow-up of Korean patients with adrenal incidentalomas. 2013

Yoon Young Cho, and Sunghwan Suh, and Ji Young Joung, and Hyemin Jeong, and Dongmo Je, and Hongseok Yoo, and Taek Kyu Park, and Yong-Ki Min, and Kwang-Won Kim, and Jae Hyeon Kim
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

OBJECTIVE We investigated the clinical characteristics and follow-up findings of subjects with adrenal incidentalomas in a single, tertiary-care hospital in South Korea. METHODS The study consisted of a retrospective analysis of 282 adrenal incidentaloma patients who underwent radiographic and endocrinological evaluations at Samsung Medical Center in Seoul, South Korea, between January 2004 and July 2011. RESULTS Most (86.2%) of the subjects were found to have nonfunctioning tumors. Functioning tumors were seen in 39 patients (13.8%). Among them, 28 (9.9%) had subclinical Cushing syndrome (SCS), six (2.1%) had pheochromocytoma, and five (1.8%) had primary hyperaldosteronism. Malignant adrenal tumors were discovered in three cases: two (0.7%) were primary adrenal cancers, and one (0.4%) was a secondary metastasis from a lung cancer. Significant risk factors for functional tumors were female gender (odds ratio [OR], 3.386; 95% confidence interval [CI], 1.611 to 7.117; p = 0.0013) and a noncontrast attenuation value of > 10 Hounsfield units (OR, 2.806; 95% CI, 1.231 to 6.397; p = 0.0141). During follow-up (mean, 22.5 months) of 72 of the patients, three (4.2%) developed hormonal changes due to functional tumors. One was confirmed as pheochromocytoma by histopathology, and the others were diagnosed with SCS and followed routinely without surgical intervention. No malignant transformation was found in these patients. CONCLUSIONS Based on these findings, initial hormonal and radiographic evaluations for adrenal incidentalomas appear to be more important than follow-up tests because functional or malignant changes are rare.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010673 Pheochromocytoma A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298) Pheochromocytoma, Extra-Adrenal,Extra-Adrenal Pheochromocytoma,Extra-Adrenal Pheochromocytomas,Pheochromocytoma, Extra Adrenal,Pheochromocytomas,Pheochromocytomas, Extra-Adrenal
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D005260 Female Females
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006929 Hyperaldosteronism A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA. Aldosteronism,Conn Syndrome,Conn's Syndrome,Primary Hyperaldosteronism,Conns Syndrome,Hyperaldosteronism, Primary,Syndrome, Conn,Syndrome, Conn's

Related Publications

Yoon Young Cho, and Sunghwan Suh, and Ji Young Joung, and Hyemin Jeong, and Dongmo Je, and Hongseok Yoo, and Taek Kyu Park, and Yong-Ki Min, and Kwang-Won Kim, and Jae Hyeon Kim
October 2002, European journal of endocrinology,
Yoon Young Cho, and Sunghwan Suh, and Ji Young Joung, and Hyemin Jeong, and Dongmo Je, and Hongseok Yoo, and Taek Kyu Park, and Yong-Ki Min, and Kwang-Won Kim, and Jae Hyeon Kim
March 2020, Endocrinology and metabolism (Seoul, Korea),
Yoon Young Cho, and Sunghwan Suh, and Ji Young Joung, and Hyemin Jeong, and Dongmo Je, and Hongseok Yoo, and Taek Kyu Park, and Yong-Ki Min, and Kwang-Won Kim, and Jae Hyeon Kim
January 2007, Hormone research,
Yoon Young Cho, and Sunghwan Suh, and Ji Young Joung, and Hyemin Jeong, and Dongmo Je, and Hongseok Yoo, and Taek Kyu Park, and Yong-Ki Min, and Kwang-Won Kim, and Jae Hyeon Kim
April 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Yoon Young Cho, and Sunghwan Suh, and Ji Young Joung, and Hyemin Jeong, and Dongmo Je, and Hongseok Yoo, and Taek Kyu Park, and Yong-Ki Min, and Kwang-Won Kim, and Jae Hyeon Kim
August 1995, Endocrine journal,
Yoon Young Cho, and Sunghwan Suh, and Ji Young Joung, and Hyemin Jeong, and Dongmo Je, and Hongseok Yoo, and Taek Kyu Park, and Yong-Ki Min, and Kwang-Won Kim, and Jae Hyeon Kim
March 2009, Journal de radiologie,
Yoon Young Cho, and Sunghwan Suh, and Ji Young Joung, and Hyemin Jeong, and Dongmo Je, and Hongseok Yoo, and Taek Kyu Park, and Yong-Ki Min, and Kwang-Won Kim, and Jae Hyeon Kim
February 1999, The Journal of clinical endocrinology and metabolism,
Yoon Young Cho, and Sunghwan Suh, and Ji Young Joung, and Hyemin Jeong, and Dongmo Je, and Hongseok Yoo, and Taek Kyu Park, and Yong-Ki Min, and Kwang-Won Kim, and Jae Hyeon Kim
April 2010, European journal of endocrinology,
Yoon Young Cho, and Sunghwan Suh, and Ji Young Joung, and Hyemin Jeong, and Dongmo Je, and Hongseok Yoo, and Taek Kyu Park, and Yong-Ki Min, and Kwang-Won Kim, and Jae Hyeon Kim
October 2016, Maturitas,
Yoon Young Cho, and Sunghwan Suh, and Ji Young Joung, and Hyemin Jeong, and Dongmo Je, and Hongseok Yoo, and Taek Kyu Park, and Yong-Ki Min, and Kwang-Won Kim, and Jae Hyeon Kim
May 2000, World journal of surgery,
Copied contents to your clipboard!